Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
Dendritic Cells + Natural Killer Cells for Ovarian Cancer
Recruiting1 awardPhase 1 & 2
Buffalo, New York
This trial is studying side effects and best dose of natural killer cell-like cytotoxic T-lymphocytes (CTLs) when given with a vaccine in treating patients with ovarian, fallopian tube, or primary peritoneal cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.